Literature DB >> 6182343

[Neuroblastoma study NBL 79 of the German Society for Pediatric Oncology. Report after 2 years].

F Berthold, J Treuner, W E Brandeis, G Evers, R J Haas, D Harms, H Jürgens, P Kaatsch, J Michaelis, D Niethammer, G Prindull, H Riehm, K Winkler, F Lampert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6182343     DOI： 10.1055/s-2008-1033815

Source DB:  PubMed          Journal:  Klin Padiatr        ISSN： 0300-8630            Impact factor:   1.349


× No keyword cloud information.
  4 in total

1.  Second malignancies in patients with neuroblastoma: the effects of risk-based therapy.

Authors:  Mark A Applebaum; Tara O Henderson; Sang Mee Lee; Navin Pinto; Samuel L Volchenboum; Susan L Cohn
Journal:  Pediatr Blood Cancer       Date:  2014-09-23       Impact factor: 3.167

2.  Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database.

Authors:  Rochelle Bagatell; Maja Beck-Popovic; Wendy B London; Yang Zhang; Andrew D J Pearson; Katherine K Matthay; Tom Monclair; Peter F Ambros; Susan L Cohn
Journal:  J Clin Oncol       Date:  2008-12-01       Impact factor: 44.544

Review 3.  The clinical application of fibroblast interferon--an overview.

Authors:  A Billiau
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

4.  [Bone marrow transplantation in acute leukemia, chronic myeloid leukemia, severe aplastic anemia and stage IV neuroblastoma. Effect of antiviral prevention with anti-CMV-hyperimmunoglobulin and acyclovir].

Authors:  P Ostendorf; G Ehninger; R Dopfer; H Schmidt; M Haen; H Link; K Schüch; C A Müller; P Wernet; T Klingebiel
Journal:  Klin Wochenschr       Date:  1986-05-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.